Global Effervescent Tablet Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	159 Pages	TechNavio	January, 2024	INF18512830

Best Price Guarantee
Price	from $2,500
Length	159 Pages
Publisher	TechNavio
Published Date	January, 2024
SKU	INF18512830

Global Effervescent Tablet Market 2024-2028

The effervescent tablet market is forecasted to grow by USD 4.80 bn during 2023-2028, accelerating at a CAGR of 8.36% during the forecast period. The report on the effervescent tablet market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing adoption of effervescent tablets among the aging population, the advantages of effervescent tablets over regular tablets, and the rising prevalence of chronic diseases.

Technavio's effervescent tablet market is segmented as below:

By Distribution Channel

Hospital pharmacy
Retail pharmacy
Online pharmacy

By Type

Prescription
Over the counter

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the availability of effervescent supplements for youth and children as one of the prime reasons driving the effervescent tablet market growth during the next few years. Also, development of organic effervescent tablets and increasing popularity of effervescent tablets on online channels will lead to sizable demand in the market.

The report on the effervescent tablet market covers the following areas:

Effervescent tablet market sizing
Effervescent tablet market forecast
Effervescent tablet market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading effervescent tablet market vendors that include Alturix Ltd., Bayer AG, Bliss GVS Pharma Ltd., Bristol Myers Squibb Co., CHIESI Farmaceutici SpA, GlaxoSmithKline Plc, Herbalife International of America Inc., HERMES PHARMA GmbH, Natur Produkt Zdrovit Sp Z O O, Nestle SA, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group Plc, SciTech Specialities Pvt Ltd., Strava Healthcare Pvt. Ltd., S. G. Biopharm Pvt. Ltd., Swisse Wellness Pty Ltd., Vitabiotics Ltd., and Vovantis Laboratories. Also, the effervescent tablet market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibit 06: Executive Summary - Chart on Market Segmentation by Type; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global effervescent tablet market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global effervescent tablet market 2018 - 2022 ($ billion); 4.2 Distribution Channel Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); 4.3 Type Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel: 6.1 Market segments; Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%); 6.2 Comparison by Distribution Channel; Exhibit 32: Chart on Comparison by Distribution Channel; Exhibit 33: Data Table on Comparison by Distribution Channel; 6.3 Hospital pharmacy - Market size and forecast 2023-2028; Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%); 6.4 Retail pharmacy - Market size and forecast 2023-2028; Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%); 6.5 Online pharmacy - Market size and forecast 2023-2028; Exhibit 42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by Distribution Channel; Exhibit 46: Market opportunity by Distribution Channel ($ billion); Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Type: 7.1 Market segments; Exhibit 48: Chart on Type - Market share 2023-2028 (%); Exhibit 49: Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Exhibit 50: Chart on Comparison by Type; Exhibit 51: Data Table on Comparison by Type; 7.3 Prescription - Market size and forecast 2023-2028; Exhibit 52: Chart on Prescription - Market size and forecast 2023-2028 ($ billion); Exhibit 53: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion); Exhibit 54: Chart on Prescription - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Prescription - Year-over-year growth 2023-2028 (%); 7.4 Over the counter - Market size and forecast 2023-2028; Exhibit 56: Chart on Over the counter - Market size and forecast 2023-2028 ($ billion); Exhibit 57: Data Table on Over the counter - Market size and forecast 2023-2028 ($ billion); Exhibit 58: Chart on Over the counter - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Over the counter - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Type; Exhibit 60: Market opportunity by Type ($ billion); Exhibit 61: Data Table on Market opportunity by Type ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 65: Chart on Geographic comparison; Exhibit 66: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 India - Market size and forecast 2023-2028; Exhibit 87: Chart on India - Market size and forecast 2023-2028 ($ billion); Exhibit 88: Data Table on India - Market size and forecast 2023-2028 ($ billion); Exhibit 89: Chart on India - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on India - Year-over-year growth 2023-2028 (%); 9.9 Germany - Market size and forecast 2023-2028; Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.10 Japan - Market size and forecast 2023-2028; Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion); Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion); Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%); 9.11 UK - Market size and forecast 2023-2028; Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 103: Market opportunity By Geographical Landscape ($ billion); Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 105: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 106: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 107: Overview on factors of disruption; 11.4 Industry risks; Exhibit 108: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 109: Vendors covered; 12.2 Market positioning of vendors; Exhibit 110: Matrix on vendor position and classification; 12.3 Alturix Ltd.; Exhibit 111: Alturix Ltd. - Overview; Exhibit 112: Alturix Ltd. - Product / Service; Exhibit 113: Alturix Ltd. - Key offerings; 12.4 Bayer AG; Exhibit 114: Bayer AG - Overview; Exhibit 115: Bayer AG - Business segments; Exhibit 116: Bayer AG - Key news; Exhibit 117: Bayer AG - Key offerings; Exhibit 118: Bayer AG - Segment focus; 12.5 Bliss GVS Pharma Ltd.; Exhibit 119: Bliss GVS Pharma Ltd. - Overview; Exhibit 120: Bliss GVS Pharma Ltd. - Business segments; Exhibit 121: Bliss GVS Pharma Ltd. - Key offerings; Exhibit 122: Bliss GVS Pharma Ltd. - Segment focus; 12.6 Bristol Myers Squibb Co.; Exhibit 123: Bristol Myers Squibb Co. - Overview; Exhibit 124: Bristol Myers Squibb Co. - Product / Service; Exhibit 125: Bristol Myers Squibb Co. - Key news; Exhibit 126: Bristol Myers Squibb Co. - Key offerings; 12.7 CHIESI Farmaceutici SpA; Exhibit 127: CHIESI Farmaceutici SpA - Overview; Exhibit 128: CHIESI Farmaceutici SpA - Product / Service; Exhibit 129: CHIESI Farmaceutici SpA - Key offerings; 12.8 GlaxoSmithKline Plc; Exhibit 130: GlaxoSmithKline Plc - Overview; Exhibit 131: GlaxoSmithKline Plc - Business segments; Exhibit 132: GlaxoSmithKline Plc - Key news; Exhibit 133: GlaxoSmithKline Plc - Key offerings; Exhibit 134: GlaxoSmithKline Plc - Segment focus; 12.9 HERMES PHARMA GmbH; Exhibit 135: HERMES PHARMA GmbH - Overview; Exhibit 136: HERMES PHARMA GmbH - Product / Service; Exhibit 137: HERMES PHARMA GmbH - Key offerings; 12.10 Natur Produkt Zdrovit Sp Z O O; Exhibit 138: Natur Produkt Zdrovit Sp Z O O - Overview; Exhibit 139: Natur Produkt Zdrovit Sp Z O O - Product / Service; Exhibit 140: Natur Produkt Zdrovit Sp Z O O - Key offerings; 12.11 Nestle SA; Exhibit 141: Nestle SA - Overview; Exhibit 142: Nestle SA - Business segments; Exhibit 143: Nestle SA - Key news; Exhibit 144: Nestle SA - Key offerings; Exhibit 145: Nestle SA - Segment focus; 12.12 Novartis AG; Exhibit 146: Novartis AG - Overview; Exhibit 147: Novartis AG - Business segments; Exhibit 148: Novartis AG - Key offerings; Exhibit 149: Novartis AG - Segment focus; 12.13 Perrigo Co. Plc; Exhibit 150: Perrigo Co. Plc - Overview; Exhibit 151: Perrigo Co. Plc - Business segments; Exhibit 152: Perrigo Co. Plc - Key news; Exhibit 153: Perrigo Co. Plc - Key offerings; Exhibit 154: Perrigo Co. Plc - Segment focus; 12.14 Pfizer Inc.; Exhibit 155: Pfizer Inc. - Overview; Exhibit 156: Pfizer Inc. - Product / Service; Exhibit 157: Pfizer Inc. - Key news; Exhibit 158: Pfizer Inc. - Key offerings; 12.15 Reckitt Benckiser Group Plc; Exhibit 159: Reckitt Benckiser Group Plc - Overview; Exhibit 160: Reckitt Benckiser Group Plc - Business segments; Exhibit 161: Reckitt Benckiser Group Plc - Key offerings; Exhibit 162: Reckitt Benckiser Group Plc - Segment focus; 12.16 S. G. Biopharm Pvt. Ltd.; Exhibit 163: S. G. Biopharm Pvt. Ltd. - Overview; Exhibit 164: S. G. Biopharm Pvt. Ltd. - Product / Service; Exhibit 165: S. G. Biopharm Pvt. Ltd. - Key offerings; 12.17 SciTech Specialities Pvt Ltd.; Exhibit 166: SciTech Specialities Pvt Ltd. - Overview; Exhibit 167: SciTech Specialities Pvt Ltd. - Product / Service; Exhibit 168: SciTech Specialities Pvt Ltd. - Key offerings
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 169: Inclusions checklist; Exhibit 170: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 171: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 172: Research methodology; Exhibit 173: Validation techniques employed for market sizing; Exhibit 174: Information sources; 13.5 List of abbreviations; Exhibit 175: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global effervescent tablet market 2018 - 2022 ($ billion); Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Distribution Channel; Exhibits33: Data Table on Comparison by Distribution Channel; Exhibits34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by Distribution Channel ($ billion); Exhibits47: Data Table on Market opportunity by Distribution Channel ($ billion); Exhibits48: Chart on Type - Market share 2023-2028 (%); Exhibits49: Data Table on Type - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Type; Exhibits51: Data Table on Comparison by Type; Exhibits52: Chart on Prescription - Market size and forecast 2023-2028 ($ billion); Exhibits53: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion); Exhibits54: Chart on Prescription - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Prescription - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Over the counter - Market size and forecast 2023-2028 ($ billion); Exhibits57: Data Table on Over the counter - Market size and forecast 2023-2028 ($ billion); Exhibits58: Chart on Over the counter - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Over the counter - Year-over-year growth 2023-2028 (%); Exhibits60: Market opportunity by Type ($ billion); Exhibits61: Data Table on Market opportunity by Type ($ billion); Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits65: Chart on Geographic comparison; Exhibits66: Data Table on Geographic comparison; Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion); Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion); Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion); Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion); Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion); Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion); Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on India - Market size and forecast 2023-2028 ($ billion); Exhibits88: Data Table on India - Market size and forecast 2023-2028 ($ billion); Exhibits89: Chart on India - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on India - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on Japan - Market size and forecast 2023-2028 ($ billion); Exhibits96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion); Exhibits97: Chart on Japan - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on Japan - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits103: Market opportunity By Geographical Landscape ($ billion); Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits105: Impact of drivers and challenges in 2023 and 2028; Exhibits106: Overview on Criticality of inputs and Factors of differentiation; Exhibits107: Overview on factors of disruption; Exhibits108: Impact of key risks on business; Exhibits109: Vendors covered; Exhibits110: Matrix on vendor position and classification; Exhibits111: Alturix Ltd. - Overview; Exhibits112: Alturix Ltd. - Product / Service; Exhibits113: Alturix Ltd. - Key offerings; Exhibits114: Bayer AG - Overview; Exhibits115: Bayer AG - Business segments; Exhibits116: Bayer AG - Key news; Exhibits117: Bayer AG - Key offerings; Exhibits118: Bayer AG - Segment focus; Exhibits119: Bliss GVS Pharma Ltd. - Overview; Exhibits120: Bliss GVS Pharma Ltd. - Business segments; Exhibits121: Bliss GVS Pharma Ltd. - Key offerings; Exhibits122: Bliss GVS Pharma Ltd. - Segment focus; Exhibits123: Bristol Myers Squibb Co. - Overview; Exhibits124: Bristol Myers Squibb Co. - Product / Service; Exhibits125: Bristol Myers Squibb Co. - Key news; Exhibits126: Bristol Myers Squibb Co. - Key offerings; Exhibits127: CHIESI Farmaceutici SpA - Overview; Exhibits128: CHIESI Farmaceutici SpA - Product / Service; Exhibits129: CHIESI Farmaceutici SpA - Key offerings; Exhibits130: GlaxoSmithKline Plc - Overview; Exhibits131: GlaxoSmithKline Plc - Business segments; Exhibits132: GlaxoSmithKline Plc - Key news; Exhibits133: GlaxoSmithKline Plc - Key offerings; Exhibits134: GlaxoSmithKline Plc - Segment focus; Exhibits135: HERMES PHARMA GmbH - Overview; Exhibits136: HERMES PHARMA GmbH - Product / Service; Exhibits137: HERMES PHARMA GmbH - Key offerings; Exhibits138: Natur Produkt Zdrovit Sp Z O O - Overview; Exhibits139: Natur Produkt Zdrovit Sp Z O O - Product / Service; Exhibits140: Natur Produkt Zdrovit Sp Z O O - Key offerings; Exhibits141: Nestle SA - Overview; Exhibits142: Nestle SA - Business segments; Exhibits143: Nestle SA - Key news; Exhibits144: Nestle SA - Key offerings; Exhibits145: Nestle SA - Segment focus; Exhibits146: Novartis AG - Overview; Exhibits147: Novartis AG - Business segments; Exhibits148: Novartis AG - Key offerings; Exhibits149: Novartis AG - Segment focus; Exhibits150: Perrigo Co. Plc - Overview; Exhibits151: Perrigo Co. Plc - Business segments; Exhibits152: Perrigo Co. Plc - Key news; Exhibits153: Perrigo Co. Plc - Key offerings; Exhibits154: Perrigo Co. Plc - Segment focus; Exhibits155: Pfizer Inc. - Overview; Exhibits156: Pfizer Inc. - Product / Service; Exhibits157: Pfizer Inc. - Key news; Exhibits158: Pfizer Inc. - Key offerings; Exhibits159: Reckitt Benckiser Group Plc - Overview; Exhibits160: Reckitt Benckiser Group Plc - Business segments; Exhibits161: Reckitt Benckiser Group Plc - Key offerings; Exhibits162: Reckitt Benckiser Group Plc - Segment focus; Exhibits163: S. G. Biopharm Pvt. Ltd. - Overview; Exhibits164: S. G. Biopharm Pvt. Ltd. - Product / Service; Exhibits165: S. G. Biopharm Pvt. Ltd. - Key offerings; Exhibits166: SciTech Specialities Pvt Ltd. - Overview; Exhibits167: SciTech Specialities Pvt Ltd. - Product / Service; Exhibits168: SciTech Specialities Pvt Ltd. - Key offerings; Exhibits169: Inclusions checklist; Exhibits170: Exclusions checklist; Exhibits171: Currency conversion rates for US$; Exhibits172: Research methodology; Exhibits173: Validation techniques employed for market sizing; Exhibits174: Information sources; Exhibits175: List of abbreviations